))
Colchicine Unveiled: A New Dawn in Cardiovascular Prevention
Manage episode 384014773 series 3393216
Innehåll tillhandahållet av Baptist Health. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Baptist Health eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Join Baptist Health Miami Cardiac & Vascular Institute experts Jonathan Fialkow, M.D., FACC, Adedapo (Dapo) Iluyomade, M.D., and Sergiu Darabant, M.D. as they discuss how this development could revolutionize the approach to combating cardiometabolic diseases through targeting inflammation, and what it means for your patients.
In this enlightening episode, we delve into the groundbreaking FDA approval of colchicine for the prevention of major adverse cardiovascular events. Join us as we explore the journey of this ancient remedy, traditionally used for gout, now emerging as a promising agent in cardioprotection. We dissect the pivotal clinical trials and evidence-based data that led to this landmark decision, shedding light on colchicine's mechanism of action and its potential role in reshaping preventive cardiology.
Guests:
Jonathan Fialkow, M.D., FACC
Chief Medical Executive for Population Health, Value and Primary Care
Deputy Director of Miami Cardiac & Vascular Institute
Chief of Cardiology, Baptist Hospital
Adedapo (Dapo) Iluyomade, M.D., Preventive Cardiologist, Baptist Health Miami Cardiac & Vascular Institute
Sergiu Darabant, M.D., Cardiologist, Baptist Health Miami Cardiac & Vascular Institute
18 episoder
Dela
